Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism

Gastroenterology

Volumn 139, Issue 3, 2010, Pages

  Novacek, Gottfried ^a   Weltermann, Ansgar ^b   Sobala, Anna ^a   Tilg, Herbert ^c   Petritsch, Wolfgang ^d   Reinisch, Walter ^a   Mayer, Andreas ^a   Haas, Thomas ^e   Kaser, Arthur ^f   Feichtenschlager, Thomas ^a   Fuchssteiner, Harry ^b   Knoflach, Peter ^g   Vogelsang, Harald ^a   Miehsler, Wolfgang ^a   Platzer, Reingard ^h   Tillinger, Wolfgang ^a   Jaritz, Bernhard ^c   Schmid, Alfons ⁱ   Blaha, Benedikt ^j   Dejaco, Clemens ^a   Eichinger, Sabine ^a   more..

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ELISABETHINEN HOSPITAL   (Austria)

^c Academic Teaching Hospital Hall in Tirol ^*  (Austria)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e PARACELSUS MEDICAL UNIVERSITY   (Austria)

^f INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^g Klinikum Wels   (Austria)

^h General Hospital Wiener Neustadt   (Austria)

ⁱ DANUBE HOSPITAL   (Austria)

^j WILHELMINEN HOSPITAL   (Austria)

more..

Author keywords

Active Disease; Crohn's Disease; Provoked Thrombosis; Ulcerative Colitis

Indexed keywords

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; ENTERITIS; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; VENOUS THROMBOEMBOLISM; AUSTRIA; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPLICATION; DRUG ADMINISTRATION; INFLAMMATORY BOWEL DISEASES; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PULMONARY EMBOLISM; RETROSPECTIVE STUDY; RISK ASSESSMENT; TIME; TREATMENT OUTCOME; VENOUS THROMBOSIS;

ANTICOAGULANT AGENT; GASTROINTESTINAL AGENT;

ADULT; ANTICOAGULANTS; AUSTRIA; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INFLAMMATORY BOWEL DISEASES; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84925581268     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.05.026     Document Type: Article

References (50)

1. W. Sloan, A. Bargen, and R. Gage Life histories of patients with chronic ulcerative colitis: a review of 2000 cases Gastroenterology 16 1950 25 38
2. F. Edwards, and S. Truelove The course and prognosis of ulcerative colitis. III. Complications Gut 5 1964 1 15
3. R.W. Talbot, J. Heppell, and R.R. Dozois Vascular complications of inflammatory bowel disease Mayo Clin Proc 61 1986 140 145
4. O. Grip, P.J. Svensson, and S. Lindgren Inflammatory bowel disease promotes venous thrombosis earlier in life Scand J Gastroenterol 35 2000 619 623
5. C.N. Bernstein, J.F. Blanchard, and D.S. Houston The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study Thromb Haemost 85 2001 430 434
6. W. Miehsler, W. Reinisch, and E. Valic Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53 2004 542 548
7. L.M. Jackson, P.J. O'Gorman, and O'Connell Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden QJM 90 1997 183 188
8. C.A. Solem, E.V. Loftus, and W.J. Tremaine Venous thromboembolism in inflammatory bowel disease Am J Gastroenterol 99 2004 97 101
9. T. Jess, M. Gamborg, and P. Munkholm Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies Am J Gastroenterol 102 2007 609 617
10. G.C. Nguyen, and J. Sam Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients Am J Gastroenterol 103 2008 1 9
11. S. Danese, A. Papa, and S. Saibeni Inflammation and coagulation in inflammatory bowel disease: the clot thickens Am J Gastroenterol 102 2007 174 186
12. M. Hudson, A. Chitolie, and R.A. Hutton Thrombotic vascular risk factors in inflammatory bowel disease Gut 38 1996 733 737
13. L. Spina, S. Saibeni, and T. Battaglioli Thrombosis in inflammatory bowel disease: role of inherited thrombophilia Am J Gastroenterol 100 2005 2036 2041
14. M.J. Grainge, J. West, and T.R. Card Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study Lancet 375 9715 2010 657 663
15. I.A. Naess, S.C. Christiansen, and P. Romundstad Incidence and mortality of venous thrombosis: a population-based study J Thromb Haemost 5 2007 692 699
16. J.D. Douketis, C.S. Gu, and S. Schulman The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism Ann Intern Med 147 2007 766 774
17. S.Z. Goldhaber, L. Visani, and M. De Rosa Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) Lancet 353 9162 1999 1386 1389
18. M. Cushman, A.W. Tsai, and R.H. White Deep vein thrombosis and pulmonary embolism in two cohorts: The Longitudinal Investigation of Thromboembolism Etiology Am J Med 117 2004 19 25
19. th edition) Chest 133 Suppl 2008 454S 545S
20. G. Palareti, and B. Cosmi Bleeding with anticoagulation therapywho is at risk, and how best to identify such patients Thromb Haemost 102 2009 268 278
21. P.A. Kyrle, and S. Eichinger Deep vein thrombosis Lancet 365 9465 2005 1163 1174
22. P. Kyrle, E. Minar, and C. Bialonczyk The risk of recurrent venous thromboembolism in men and women N Engl J Med 350 2004 2558 2563
23. S. McRae, H. Tran, and S. Schulman Effect of patient′s sex on risk of recurrent venous thromboembolism: a meta-analysis Lancet 368 2006 371 378
24. P. Prandoni, A.W. Lensing, and A. Cogo The long-term clinical course of acute deep venous thrombosis Ann Intern Med 125 1996 1 7
25. J.A. Baron, G. Gridley, and E. Weiderpass Venous thromboembolism and cancer Lancet 351 1998 1077 1080
26. P.A. Kyrle, E. Minar, and M. Hirschl High plasma levels of factor VIII and the risk of recurrent venous thromboembolism N Engl J Med 343 2000 457 462
27. A. Weltermann, S. Eichinger, and D. Bialonczyk The risk of recurrent venous thromboembolism among patients with high factor IX levels J Thromb Haemost 1 2003 28 32
28. S. Eichinger, G. Hron, and C. Bialonczyk Overweight, obesity, and the risk of recurrent venous thromboembolism Arch Intern Med 168 2008 1678 1683
29. J.P. Vandenbroucke, E. von Elm, and D.G. Altmann Strengthening of reporting of observational studies in epidemiology (STROBE): explanation and elaboration Ann Intern Med 147 2007 W163 W194
30. E.F. Stange, S.P. Travis, and S. Vermeire European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis Gut 55 Suppl 1 2006 i1 i15
31. E.F. Stange, S.P.L. Travis, and S. Vermeire European evidence based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis J Crohns Colitis 2 2008 1 23
32. M. Goteway, K. Edinburgh, and V. Feldstein Imaging evaluation of suspected pulmonary embolism Curr Probl Diagn Radiol 28 1999 129 184
33. The PIOPED Investigators Value of the ventilation/perfusion scan in acute pulmonary embolism: results of the Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED) JAMA 263 1990 2753 2769
34. M.S. Silverberg, J. Satsangi, and T. Ahmad Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology Can J Gastroenterol 19 Suppl A 2005 5 36
35. R.F. Harvey, and J.M. Bradshaw A simple index of Crohn's disease activity Lancet 1 8167 1980 514
36. R.S. Walmsley, R.C.S. Ayres, and R.E. Pounder A simple clinical colitis activity index Gut 43 1998 29 32
37. P.D.R. Higgins, M. Schwartz, and J. Mapili Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis Gut 54 2005 782 788
38. G. D'Haens, W.J. Sandborn, and B.G. Feagan A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis Gastroenterology 132 2007 763 786
39. M.F. Picco, and T.M. Bayless Tobacco consumption and disease duration are associated with fistulizing and structuring behaviours in the first 8 years of Crohn's disease Am J Gastroenterol 98 2003 363 368
40. R.M. Bertina, B.P. Koeleman, and T. Koster Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67
41. S.R. Poort, F.R. Rosendaal, P.H. Reitsma, and R.M. Bertina A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis Blood 88 1996 3698 3703
42. J.T. Brandt, D.A. Triplett, B. Alving, and I. Scharrer Criteria for the diagnosis of lupus anticoagulants: an update Thromb Haemost 74 1995 1185 1190
43. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
44. E. Whitley, and J. Ball Statistics review 4: sample size calculation Crit Care 6 2002 335 341
45. L. Eischer, S. Eichinger, and P.A. Kyrle Age at first venous thromboembolism and risk of recurrence: a prospective cohort study Medicine (Baltimore) 88 2009 366 370
46. P. Prandoni, F. Noventa, and A. Ghirarduzzi The risk of recurrent venous thromboembolism after discontinuing anticoaglation in patients with acute proximal deep vein thrombosis or pulmonary embolism A prospective cohort study in 1626 patients Haematologica 92 2007 199 205
47. T. Zhu, I. Martinez, and J. Emmerich Venous thromboembolism: risk factors for recurrence Arterioscler Thromb Vasc Biol 29 2009 298 310
48. S. Danese, J. Katz, and S. Daibeni Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients Gut 52 2003 1435 1441
49. A.R. Folsom, P.L. Lutsey, and B.C. Astor C-reactive protein and venous thromboembolism A prospective investigation in the ARIC cohort Thromb Haemost 102 2009 615 619
50. J. Shen, Z.H. Ran, and J.L. Tong Meta-analysis: the utility and safety of heparin in the treatment of active ulcerative colitis Aliment Pharmacol Ther 26 2007 653 663